FDA Inspection 1037724 — Kaneka Eurogentec SA
The FDA completed an inspection of Kaneka Eurogentec SA on October 27, 2017 in Seraing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 27, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Seraing (Belgium)